Gene therapy cures might not deliver sustainable sales: analyst by Arlene Weintraub Thursday, April 12, 2018 This week, Goldman Sachs resurrected a burning question: How can pharma companies profit from curing patients with one-time gene and cell therapies?
Allergan enlists rapper Common to push eye screenings by Carly Helfand Tuesday, March 14, 2017 After launching a vision-loss awareness effort last month, Allergan has teamed up with its first celebrity spokesman: Common.
